Effector phase immunity
Brain cancer, Immunotherapy, Nanomedicines
Research aim
Our research focusses on the effector immune response of cytotoxic (killer) cells in brain cancer. We aim to translate this knowledge into (cellular) immunotherapy and nanomedicines that mimic effector phase immunity to target cancer.
About us
Biomedical Research:
My biomedical research focusses on the effector immune response of cytotoxic (killer) cells in brain cancer, with a particular focus on pediatric medulloblastoma. We aim to translate this knowledge into (cellular) immunotherapy and nanomedicines that mimic effector phase immunity to target cancer. These aims fit within UMC Utrecht focus areas Cancer and Immunity & Infection, and UU strategic theme area Life Sciences.
Educational Research:
My educational research and vision aim to enhance training of future T-shaped professionals that are equipped with the knowledge and skills to solve todays big challenges in healthcare in benefit for society. We foster student learning and training of academic skills in translational medicine, such as critical thinking, creative problem solving, (multidisciplinary) collaboration, and communication. To this end, we develop novel patient-centred educational concepts grounded in inquiry-based learning (learn by doing), inter/transdisciplinary learning (learn by collaboration), and challenge/research-based learning (learn via real world authentic cases), involving patients, researchers, medical doctors (learn with role-models). We also scholarly investigate our educational innovations on teaching and learning. This research fits within UMC Utrecht strategy Connecting Worlds, the Educational Center strategy New Utrecht School, and UU focus area Higher Education Research.